Benitec Biopharma Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Benitec Biopharma Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2019 to Q3 2024.
  • Benitec Biopharma Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $732K.
  • Benitec Biopharma Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $1.55M.
  • Benitec Biopharma Inc. annual Nonoperating Income (Expense) for 2024 was $739K.
  • Benitec Biopharma Inc. annual Nonoperating Income (Expense) for 2023 was -$481K, a 35.9% decline from 2022.
  • Benitec Biopharma Inc. annual Nonoperating Income (Expense) for 2022 was -$354K, a 23.8% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.55M $732K +$812K Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $739K $828K +$939K Apr 1, 2024 Jun 30, 2024 10-K 2024-09-26
Q1 2024 -$200K -$138K -$82K -146% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$118K $129K -$70K -35.2% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q3 2023 -$48K -$80K +$433K +84.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$481K -$111K +$219K +66.4% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-26
Q1 2023 -$700K -$56K -$241K -130% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$459K $199K +$185K +1321% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 -$644K -$513K -$290K -130% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$354K -$330K -$181K -121% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-21
Q1 2022 -$173K $185K +$301K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$474K $14K +$7K +100% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-13
Q3 2021 -$481K -$223K -$195K -696% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$286K -$149K -$107K -255% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-02
Q1 2021 -$179K -$116K -$125K -1389% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$54K $7K -$14K -66.7% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 -$40K -$28K -$47K -247% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $7K -$42K Apr 1, 2020 Jun 30, 2020 10-K 2021-09-20
Q1 2020 $9K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $21K Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 $19K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.